Fabian reported progress on her study of the effects of 6-month treatment with tirzepatide on risk biomarkers for the development of breast cancer, including absolute fibroglandular volume (FGV), visceral fat, and others
Hamacher D, Liebl D, Hold C, Hessler V, Kniewasser CK, Thonnessen T, et al
These individuals include: Allergy or hypersensitivity to GLP-1 medications Type 1 diabetes Pancreatitis Gastroparesis Medullary thyroid cancer Multiple endocrine neoplasia type 2 or family history of these conditions Pregnant, nursing, or trying to become pregnant Individuals with renal impairment Active eating disorder or history of disordered eating As always, the decision to use GLP-1s should be made in consultation with a healthcare professional who can assess an individual's medical history and overall health to determine if the medication is suitable for them
Notably, EV-associated DAMPs have been found in stored red blood concentrates [238], suggesting that eryptosis-mediated generation of EVs might exert immunomodulatory DAMP-triggered effects
There are several steps involved in preparing and administering semaglutide injections